Federal Circuit: Moderna’s COVID-19 Vaccine Did Not Infringe On Patented Lipid
WASHINGTON, D.C. — A Delaware federal judge rightly held that a COVID-19 vaccine from Moderna Inc. and related entities does not infringe on a biopharmaceutical company’s patents related to a type...To view the full article, register now.
Already a subscriber? Click here to view full article